Maximizing Early Dementia Detection Through Medicare Annual Wellness Visits.
作者信息
Aliberti Márlon Juliano Romero, Avelino-Silva Thiago J, Suemoto Claudia Kimie
机构信息
Laboratorio de Investigacao Medica em Envelhecimento (LIM-66), Servico de Geriatria, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.
Research Institute, Hospital Sirio-Libanes, Sao Paulo, Brazil.
出版信息
JAMA Netw Open. 2024 Oct 1;7(10):e2437162. doi: 10.1001/jamanetworkopen.2024.37162.
Abstract
摘要
相似文献
1
Maximizing Early Dementia Detection Through Medicare Annual Wellness Visits.通过医疗保险年度健康检查实现早期痴呆症检测的最大化。
JAMA Netw Open. 2024 Oct 1;7(10):e2437162. doi: 10.1001/jamanetworkopen.2024.37162.
2
Annual Wellness Visits and Early Dementia Diagnosis Among Medicare Beneficiaries.医疗保险受益人的年度健康访视和早期痴呆诊断。
JAMA Netw Open. 2024 Oct 1;7(10):e2437247. doi: 10.1001/jamanetworkopen.2024.37247.
3
The effect of direct cognitive assessment in the Medicare annual wellness visit on dementia diagnosis rates.直接认知评估在 Medicare 年度健康访视中对痴呆症诊断率的影响。
Health Serv Res. 2021 Apr;56(2):193-203. doi: 10.1111/1475-6773.13627. Epub 2021 Jan 22.
4
Improving dementia care: the role of screening and detection of cognitive impairment.改善痴呆症护理：筛查和检测认知障碍的作用。
Alzheimers Dement. 2013 Mar;9(2):151-9. doi: 10.1016/j.jalz.2012.08.008. Epub 2013 Jan 30.
5
Identifying cognitive impairment during the Annual Wellness Visit: who can you trust?在年度健康检查中识别认知障碍：你能信任谁？
J Fam Pract. 2011 Nov;60(11):653-9.
6
The Effectiveness of Medicare Wellness Visits in Accessing Preventive Screening.医疗保险健康检查在进行预防性筛查方面的有效性。
J Prim Care Community Health. 2017 Oct;8(4):247-255. doi: 10.1177/2150131917736613. Epub 2017 Oct 28.
7
Preventive Care and Outcomes of Interprofessional Medicare Annual Wellness Visits for Older Adults.老年医疗保险年度健康访视的多专业协作预防保健和效果。
Int J Environ Res Public Health. 2022 Dec 13;19(24):16752. doi: 10.3390/ijerph192416752.
8
The Effect of Medicare Annual Wellness Visits on Breast Cancer Screening and Diagnosis.医疗保险年度健康访视对乳腺癌筛查和诊断的影响。
Med Care. 2024 Aug 1;62(8):530-537. doi: 10.1097/MLR.0000000000002023. Epub 2024 Jun 11.
9
After Risk-Adjustment Change, Dementia Diagnoses Increased In Medicare Advantage Relative To Traditional Medicare.在风险调整变化之后，与传统医疗保险相比，医疗保险优势计划中的痴呆症诊断有所增加。
Health Aff (Millwood). 2025 Jan;44(1):81-89. doi: 10.1377/hlthaff.2024.00723.
10
Evaluation of Pharmacist-led Telehealth Medicare Annual Wellness Visits to Satisfy Quality Metrics and USPSTF Recommendations After Implementation of a Post-Visit Follow-Up Protocol.实施访后随访方案后，评估药剂师主导的远程医疗医疗保险年度健康检查以满足质量指标和美国预防服务工作组的建议。
J Pharm Pract. 2025 Aug;38(4):364-369. doi: 10.1177/08971900241296638. Epub 2024 Oct 30.
引用本文的文献
1
What Helps or Hinders Annual Wellness Visits for Detection and Management of Cognitive Impairment Among Older Adults? A Scoping Review Guided by the Consolidated Framework for Implementation Research.哪些因素有助于或阻碍老年人进行年度健康检查以检测和管理认知障碍？一项以实施研究综合框架为指导的范围综述
Nurs Rep. 2025 Aug 12;15(8):295. doi: 10.3390/nursrep15080295.
2
Subjective memory complaints of patients and caregivers and their association with sociodemographic and clinical factors in patients with neurocognitive disorders from Colombia.哥伦比亚神经认知障碍患者及其照料者的主观记忆主诉及其与社会人口学和临床因素的关联
Res Sq. 2025 Jul 14:rs.3.rs-7040277. doi: 10.21203/rs.3.rs-7040277/v1.
3
From suspicion of cognitive decline to dementia diagnosis: a systematic review of healthcare professionals' considerations and attitudes.从认知能力下降的怀疑到痴呆症诊断：对医疗保健专业人员的考量与态度的系统评价
Age Ageing. 2025 May 31;54(6). doi: 10.1093/ageing/afaf176.
4
Pulling Back the Curtain on Hospital Dementia Detection: Validation of the Informant-Based Clinical Dementia Rating.揭开医院痴呆症检测的面纱：基于 informant 的临床痴呆评定量表的验证
J Am Geriatr Soc. 2025 Aug;73(8):2524-2530. doi: 10.1111/jgs.19494. Epub 2025 May 2.
本文引用的文献
1
Annual Wellness Visits and Early Dementia Diagnosis Among Medicare Beneficiaries.医疗保险受益人的年度健康访视和早期痴呆诊断。
JAMA Netw Open. 2024 Oct 1;7(10):e2437247. doi: 10.1001/jamanetworkopen.2024.37247.
2
The FDA-approved anti-amyloid-β monoclonal antibodies for the treatment of Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials.经 FDA 批准用于治疗阿尔茨海默病的抗淀粉样蛋白-β单克隆抗体：一项随机对照试验的系统评价和荟萃分析。
Eur J Med Res. 2023 Nov 28;28(1):544. doi: 10.1186/s40001-023-01512-w.
3
Evaluation of major national dementia policies and health-care system preparedness for early medical action and implementation.评估主要国家的痴呆症政策和卫生保健系统，为早期医疗行动和实施做好准备。
Alzheimers Dement. 2022 Oct;18(10):1993-2002. doi: 10.1002/alz.12655. Epub 2022 Mar 16.
4
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019.2019 年全球痴呆症患病率估计及 2050 年预测患病率：2019 年全球疾病负担研究分析。
Lancet Public Health. 2022 Feb;7(2):e105-e125. doi: 10.1016/S2468-2667(21)00249-8. Epub 2022 Jan 6.
5
Underdiagnosis of Dementia: an Observational Study of Patterns in Diagnosis and Awareness in US Older Adults.痴呆症漏诊：美国老年人诊断和认知模式的观察性研究。
J Gen Intern Med. 2018 Jul;33(7):1131-1138. doi: 10.1007/s11606-018-4377-y. Epub 2018 Mar 5.
6
The Effectiveness of Medicare Wellness Visits in Accessing Preventive Screening.医疗保险健康检查在进行预防性筛查方面的有效性。
J Prim Care Community Health. 2017 Oct;8(4):247-255. doi: 10.1177/2150131917736613. Epub 2017 Oct 28.
7
Timely Diagnosis for Alzheimer's Disease: A Literature Review on Benefits and Challenges.阿尔茨海默病的及时诊断：关于益处与挑战的文献综述
J Alzheimers Dis. 2016;49(3):617-31. doi: 10.3233/JAD-150692.
Zotero 插件